Alexza Pharma (ALXA) Short Interest Rises into Adasuve Panel Vote
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Alexza Pharma (ALXA) Receives Positive Opinion on ADASUVE from CHMP
December 14, 2012 8:09 AM ESTAlexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Grupo Ferrer Internacional, S.A., today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending that ADASUVE (Staccato loxapine) be granted European Union (EU) centralized marketing... More
EMA issues positive recommendation for Alexza's (ALXA) Adasuve
December 14, 2012 7:14 AM ESTEMA issues positive recommendation for Alexza Pharmaceuticals' (NASDAQ: ALXA) Adasuve. (note: Shares currently halted)... More
Alexza Pharmaceuticals Inc. (ALXA) halted, news pending
December 14, 2012 7:04 AM ESTAlexza Pharmaceuticals Inc. (NASDAQ: ALXA) halted, news pending... More
